Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF (APPROACH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02789917
Recruitment Status : Completed
First Posted : June 3, 2016
Last Update Posted : August 14, 2020
Sponsor:
Collaborators:
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Technische Universität München
Helmholtz Zentrum München
University of Göttingen
University of München
University Medicine Greifswald
Information provided by (Responsible Party):
Reza Wakili, Klinikum der Universitaet Muenchen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2020
Actual Study Completion Date : August 2020